Radboudumc
This joint project will be performed at Amsterdam UMC (Department of Psychiatry - Dr. Hilgo Bruining research group) as well as the Radboudumc (Department of Health Evidence - Prof. Gert Jan van der Wilt research group). At these places, you will work in a team with young and enthusiastic researchers, who have expertise in Bayesian statistical analysis, conductance of clinical trials, health technology assessment, cell biology, neuroscience and clinical neurology and psychiatry.
The project is funded by an NWO-NWA-ORC grant (New, rational therapy decisions for developmental brain disorders: Integrating quantitative patient assessment, cellular assays and nanotechnology (NewTDec)) and embedded in the following research institutes: UMC Amsterdam, Twente University and the Radboud Institute for Health Sciences. People of the consortium are: Prof. Matthijs Verhage, Dr. Hilgo Bruining, Dr. Klaus Linkenkaer-Hansen, Dr. Niels Cornelisse, Dr. Niels Tas, Prof. Gert Jan van der Wilt.
RadboudumcRadboudumc strives to be a leading developer of sustainable, innovative and affordable healthcare to improve the health and wellbeing of people and society in the Netherlands and beyond. This is the core of our mission: To have a significant impact on healthcare. To get a better picture of what this entails, check out our
strategy.
Read more about what it means
to work at Radboudumc and how you can do your part.